Publication:
The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.

dc.contributor.authorGarzotto, F
dc.contributor.authorOstermann, M
dc.contributor.authorMartín-Langerwerf, D
dc.contributor.authorSánchez-Sánchez, M
dc.contributor.authorTeng, J
dc.contributor.authorRobert, R
dc.contributor.authorMarinho, A
dc.contributor.authorHerrera-Gutierrez, M E
dc.contributor.authorMao, H J
dc.contributor.authorBenavente, D
dc.contributor.authorKipnis, E
dc.contributor.authorLorenzin, A
dc.contributor.authorMarcelli, D
dc.contributor.authorTetta, C
dc.contributor.authorRonco, C
dc.contributor.authoraffiliation[Garzotto,F; Ronco,C] Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy. [Garzotto,F; Lorenzin,A; Ronco,C] International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy. [Ostermann,M] Department of Critical Care, King’s College London, Guy’s and St Thomas’ Hospital, UK. [Martín-Langerwerf,D] Servicio de Medicina Intensiva, Hospital Universitario del Vinalopo, Elche, Spain. [Sánchez-Sánchez,M] Intensive Care, Hospital Universitario La Paz/Carlos III. IdiPAZ, Madrid, Spain. [Teng,J] Department of Nephrology, Shanghai Institute of Kidney and Dialysis, Shanghai Key Laboratory of Kidney and Blood Purification, Zhongshan Hospital, Fudan University, Shanghai, China. [Robert,R] Medical Intensive Care, University of Poitiers; CHU Poitiers, France. [Marinho,A] Intensive Care Service, St Antonio Hospital –Porto, Portugal. [Herrera-Gutierrez,ME] Intensive Care Unit, General University Hospital, Malaga, Spain. [Mao,HJ] Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, China. [Benavente,D] Department of Nephrology, Clinica Las Condes, Estoril Santiago, Chile. [Kipnis,E] Department of Anesthesiology and Critical Care, University Hospital, Lille, France. [Marcelli,D; Tetta,C] Fresenius Medical Care, Bad Homburg, Germany.es
dc.contributor.groupThe DoReMiFa study groupes
dc.date.accessioned2016-09-06T11:40:28Z
dc.date.available2016-09-06T11:40:28Z
dc.date.issued2016-06-23
dc.descriptionJOURNAL ARTICLE;es
dc.description.abstractBACKGROUND The previously published "Dose Response Multicentre International Collaborative Initiative (DoReMi)" study concluded that the high mortality of critically ill patients with acute kidney injury (AKI) was unlikely to be related to an inadequate dose of renal replacement therapy (RRT) and other factors were contributing. This follow-up study aimed to investigate the impact of daily fluid balance and fluid accumulation on mortality of critically ill patients without AKI (N-AKI), with AKI (AKI) and with AKI on RRT (AKI-RRT) receiving an adequate dose of RRT. METHODS We prospectively enrolled all consecutive patients admitted to 21 intensive care units (ICUs) from nine countries and collected baseline characteristics, comorbidities, severity of illness, presence of sepsis, daily physiologic parameters and fluid intake-output, AKI stage, need for RRT and survival status. Daily fluid balance was computed and fluid overload (FO) was defined as percentage of admission body weight (BW). Maximum fluid overload (MFO) was the peak value of FO. RESULTS We analysed 1734 patients. A total of 991 (57 %) had N-AKI, 560 (32 %) had AKI but did not have RRT and 183 (11 %) had AKI-RRT. ICU mortality was 22.3 % in AKI patients and 5.6 % in those without AKI (p < 0.0001). Progressive fluid accumulation was seen in all three groups. Maximum fluid accumulation occurred on day 2 in N-AKI patients (2.8 % of BW), on day 3 in AKI patients not receiving RRT (4.3 % of BW) and on day 5 in AKI-RRT patients (7.9 % of BW). The main findings were: (1) the odds ratio (OR) for hospital mortality increased by 1.075 (95 % confidence interval 1.055-1.095) with every 1 % increase of MFO. When adjusting for severity of illness and AKI status, the OR changed to 1.044. This phenomenon was a continuum and independent of thresholds as previously reported. (2) Multivariate analysis confirmed that the speed of fluid accumulation was independently associated with ICU mortality. (3) Fluid accumulation increased significantly in the 3-day period prior to the diagnosis of AKI and peaked 3 days later. CONCLUSIONS In critically ill patients, the severity and speed of fluid accumulation are independent risk factors for ICU mortality. Fluid balance abnormality precedes and follows the diagnosis of AKI.es
dc.description.versionYeses
dc.identifier.citationGarzotto F, Ostermann M, Martín-Langerwerf D, Sánchez-Sánchez M, Teng J, Robert R, et al. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. Crit Care. 2016; 20(1):196es
dc.identifier.doi10.1186/s13054-016-1355-9
dc.identifier.essn1466-609X
dc.identifier.issn1364-8535
dc.identifier.pmcPMC4918119
dc.identifier.pmid27334608
dc.identifier.urihttp://hdl.handle.net/10668/2397
dc.journal.titleCritical Care (London, England)
dc.language.isospa
dc.publisherBiomed Centrales
dc.relation.publisherversionhttp://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1355-9#Abs1es
dc.rights.accessRightsopen access
dc.subjectFluid overloades
dc.subjectRRTes
dc.subjectAKIes
dc.subjectCritical illnesses
dc.subjectICUes
dc.subjectEstudios de seguimientoes
dc.subjectMortalidad hospitalariaes
dc.subjectHumanoses
dc.subjectUnidades de cuidados intensivoses
dc.subjectAnálisis multifactoriales
dc.subjectCociente de probabilidadeses
dc.subjectTratamiento de reemplazo renales
dc.subjectFactores de riesgoes
dc.subjectSepsises
dc.subjectEquilibrio hidroelectrolíticoes
dc.subjectLesión renal agudaes
dc.subjectPeso corporales
dc.subjectComorbilidades
dc.subjectIntervalos de confianzaes
dc.subjectEnfermedad críticaes
dc.subject.meshMedical Subject Headings::Diseases::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Acute Kidney Injuryes
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Physiological Phenomena::Physiological Processes::Growth and Development::Growth::Body Size::Body Weightes
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Comorbidityes
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Confidence Intervalses
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illnesses
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Follow-Up Studieses
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality::Hospital Mortalityes
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Health Care::Health Care Facilities, Manpower, and Services::Health Facilities::Hospital Units::Intensive Care Unitses
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Analysis of Variance::Multivariate Analysises
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Probability::Odds Ratioes
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Renal Replacement Therapyes
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Causality::Risk Factorses
dc.subject.meshMedical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Sepsises
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Physiological Phenomena::Physiological Processes::Homeostasis::Water-Electrolyte Balancees
dc.titleThe Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.es
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
GarzottoF_TheDoseResponseMulticentre.pdf
Size:
2.41 MB
Format:
Adobe Portable Document Format
Description:
Artículo publicado
No Thumbnail Available
Name:
GarzottoF_TheDoseResponse_AdditionalFile1.docx
Size:
251.06 KB
Format:
Microsoft Word XML
Description:
File 1
No Thumbnail Available
Name:
GarzottoF_TheDoseResponse_AdditionalFile2.docx
Size:
19.35 KB
Format:
Microsoft Word XML
Description:
File 2